Ning Meng
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Atherosclerosis and Cardiovascular Diseases 7
- Co-authors
- Le Su (6 shared papers)Bao‐Xiang Zhao (4 shared papers)Jun‐Ying Miao (5 shared papers)Runliang Feng (7 shared papers)Zhimei Song (7 shared papers)Cheng‐Shi Jiang (14 shared papers)ShangLi Zhang (2 shared papers)Shangli Zhang (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Anti-Cancer Agents in Medicinal Chemistry (3 papers)Free Radical Biology and Medicine (2 papers)Chemistry & Biodiversity (2 papers)Cell Biochemistry and Function (2 papers)
- Partner nations
- ChinaSudanSaudi Arabia
In The Last Decade
Ning Meng
38 papers receiving 760 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 119
- Biomaterials 96
- Pharmaceutical Science 47
- Molecular Medicine 32
- Immunology 85
Countries citing papers authored by Ning Meng
This map shows the geographic impact of Ning Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Meng more than expected).
Fields of papers citing papers by Ning Meng
This network shows the impact of papers produced by Ning Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Meng. The network helps show where Ning Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 143 | |
| 2 | 2015 | 137 | |
| 3 | 2018 | 55 | |
| 4 | 2017 | 45 | |
| 5 | 2014 | 34 | |
| 6 | 2018 | 33 | |
| 7 | 2019 | 29 | |
| 8 | 2018 | 27 | |
| 9 | 2022 | 26 | |
| 10 | 2017 | 25 | |
| 11 | 2020 | 23 | |
| 12 | 2018 | 22 | |
| 13 | 2015 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2016 | 17 | |
| 16 | 2014 | 12 | |
| 17 | 2016 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2024 | 10 | |
| 20 | 2022 | 9 |
About Ning Meng
Ning Meng is a scholar working on Immunology, Pharmaceutical Science, Biomaterials, Molecular Biology and Molecular Medicine, having authored 40 papers that have together received 780 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (7 papers), Genomics, phytochemicals, and oxidative stress (7 papers), Ferroptosis and cancer prognosis (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Autophagy in Disease and Therapy (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Synthesis and biological activity (4 papers) and Curcumin's Biomedical Applications (3 papers). The work is most often cited by research in Cancer Research (119 citations), Biomaterials (96 citations), Pharmaceutical Science (47 citations), Molecular Medicine (32 citations) and Immunology (85 citations). Ning Meng has collaborated with scholars based in China, Sudan and Saudi Arabia. Frequent co-authors include Le Su, Bao‐Xiang Zhao, Jun‐Ying Miao, Runliang Feng, Zhimei Song, Cheng‐Shi Jiang, ShangLi Zhang, Shangli Zhang, Nan Peng and Ying Li. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Anti-Cancer Agents in Medicinal Chemistry, Free Radical Biology and Medicine, Chemistry & Biodiversity and Cell Biochemistry and Function.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.